quazepam is indicated for the treatment of insomnia including sleep induction and sleep maintenance quazepam induces impairment of motor function and has relatively and uniquely selective hypnotic and anticonvulsant properties with considerably less overdose potential than other benzodiazepines due to its novel receptor subtype selectively quazepam is an effective hypnotic which induces and maintains sleep without disruption of the sleep architecture it was patented in 1970 and came into medical use in 1985 quazepam is used for short term treatment of insomnia related to sleep induction or sleep maintenance problems and has demonstrated superiority over other benzodiazepines such as temazepam it had a fewer incidence of side effects than temazepam including less sedation amnesia and less motor impairment usual dosage is 7 5 to 15 mg orally at bedtime quazepam is effective as a premedication prior to surgery quazepam has fewer side effects than other benzodiazepines and less potential to induce tolerance and rebound effects there is significantly less potential for quazepam to induce respiratory depression or to adversely affect motor coordination than other benzodiazepines the different side effect profile of quazepam may be due to its more selective binding profile to type 1 benzodiazepine receptors tolerance may occur to